source
- Asahi Kasei Therapeutics receives FDA approval for HSV drug acquired in $1 billion dealAsahi Kasei Therapeutics announced that the U.S. Food and Drug Administration granted approval for its herpes simplex virus (HSV) therapy. The drug, called Hovilpri, was purchased by Asahi Kasei e…
- Strategic CDMO partnerships shift from transactional to collaborative, emphasizing risk sharing and regulatory expertiseCDMO-sponsor relationships are moving away from simple outsourcing toward deeper strategic collaboration. Companies now look for partners who share risk, understand regulatory requirements, and pro…